Budget Battles
-
Biden Jacks Up Tariffs on $18 Billion in Chinese Imports
-
Trump Promises New Tax Cuts for Everyone
-
Biden White House Lays Out Plan for Coming Tax Showdown
-
Trump Tax Cut Extension Would Cost $4.6 Trillion: CBO
-
House Kills Greene Motion to Oust Speaker Johnson
-
Greene Backs Off Johnson Threat, but Issues Four Demands
-
Social Security, Medicare Get Boost From Strong Economy
-
1 in 8 US Adults Has Taken Ozempic or Other GLP-1 Drug: Survey
About 12% of American adults say they have used one of the increasingly popular weight loss and diabetes drugs known as GLP-1s, and 6% say they are currently taking such a drug, according to a new...
-
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead: Report
Eight drug companies that make the 10 medications whose prices are currently being negotiated by Medicare spent billions more last year on stock buybacks, dividends, marketing and administrative...
-
Social Security, Medicare Get Modest Boost From Strong Economy
By Michael RaineySolid economic growth in the wake of the pandemic has strengthened some of the nation’s leading social safety net programs, as robust employment increases the flow of payments into the Social...
-
Nearly 1 in 4 of Those Removed From Medicaid Now Uninsured
By Michael RaineyMillions of Americans have been removed from state-level Medicaid programs over the last year, following the official end of the Covid-19 pandemic and the return to pre-pandemic rules governing...
-
Biden Touts Healthcare Progress With Support From a Former Rival
President Joe Biden and Sen. Bernie Sanders joined forced on Wednesday to promote the administration’s efforts to lower healthcare costs and prescription drug prices, an issue that the White House...
-
Study Raises Questions About Ozempic Cost as Medicare Spending Soars
Some widely used diabetes and weight loss drugs could be profitably manufactured for far less than they currently cost, according to a new study. The analysis, published in JAMA Network Open by...
-
Drugmakers Push Back Against Price Negotiations
By Michael RaineyMajor pharmaceutical firms are fighting a new federal program that empowers the government to negotiate lower prices for drugs that are widely prescribed in the Medicare system. The Washington Post’s...
-
Biden Proposes a $7.3 Trillion Budget for 2025
President Biden on Monday proposed a $7.3 trillion budget for fiscal year 2025 that seeks to lower the costs of prescription drugs, child care and housing while also cutting the deficit by $3...
-
UnitedHealth Faces New Justice Department Antitrust Probe: Reports
The Justice Department has reportedly launched an antitrust investigation into UnitedHealth, the nation’s largest health insurer and a top manager of pharmacy benefits and physician groups...
-
Americans’ Top Financial Worry: Healthcare
By Michael RaineyHealthcare issues claim the top spots in the list of things U.S. voters are “very” or “somewhat worried” about being able to afford, according to the latest tracking poll from the healthcare...
-
New Record for Obamacare Signups
By Michael RaineyA record 20 million people have signed up for health care through the marketplaces created by the Affordable Care Act, the Centers for Medicare and Medicaid Services announced Wednesday. This marks...
-
As Drug Prices Rise, $35 Cap on Insulin Takes Effect
By Michael RaineyPharmaceutical companies rang in the New Year as they usually do: raising prices on hundreds of medications. According to research cited by Reuters , companies like Pfizer, Sanofi and Takeda will...
-
More Than Half of Children Losing Medicaid Coverage Live in Just 5 States
By Michael RaineyAs individual states continue to disenroll millions of people from Medicaid and the Children’s Health Insurance Program (CHIP) now that pandemic-era suspension of participation guidelines has come to...
-
Biden Admin Threatens to Seize Publicly Funded Drug Patents
By Michael RaineyThe Biden administration took steps Thursday that could clear the way for the federal government to seize the patents of high-priced pharmaceuticals that were developed using public funds. The move...
-
CVS Says It Will Overhaul How It Prices Prescription Drugs
Drugstore giant CVS Health announced Tuesday that it is dramatically changing the way its pharmacies are reimbursed for prescription medications, shifting to a model that it says is simpler and more...